{"text": "Increased <extra_id_0> IL-17 <extra_id_2> Protein <extra_id_1> production in PBMC of patients with RA by anti-CD3 and / or anti - <extra_id_0> CD28 <extra_id_2> Protein <extra_id_1> , and <extra_id_0> PHA <extra_id_2> Protein <extra_id_1>", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Because <extra_id_0> IL-17 <extra_id_2> Protein <extra_id_1> was already known from earlier reports to be produced mainly by activated T cells , we investigated the effect of different concentrations of anti-CD3 ( 1 , 5 and 10 mug / ml ) as a T cell activation , which showed a dose - dependent increase in <extra_id_0> IL-17 <extra_id_2> Protein <extra_id_1> levels ( data not shown ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "On the basis of this , we chose 10 mug / ml as a stimulation concentration for anti-CD3 .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "As shown in Table 1 , anti-CD3 significantly upregulated <extra_id_0> IL-17 <extra_id_2> Protein <extra_id_1> production up to 3.7-fold , and the combination of anti - <extra_id_0> CD28 <extra_id_2> Protein <extra_id_1> and anti-CD3 produced more <extra_id_0> IL-17 <extra_id_2> Protein <extra_id_1> ( approximately 1.3-1.5-fold ) than anti-CD3 alone .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Furthermore , when incubated with T cell mitogens such as <extra_id_0> PHA <extra_id_2> Protein <extra_id_1> , increased <extra_id_0> IL-17 <extra_id_2> Protein <extra_id_1> production was more pronounced than with anti-CD3 and anti - <extra_id_0> CD28 <extra_id_2> Protein <extra_id_1> ( 588 +/- 85 versus 211 +/- 1 pg / ml ; P < 0.05 ) .", "event": "<extra_id_0> <extra_id_1>"}
